[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Emanuele Barabino\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100610658","artificial-intelligence-for-the-intra-procedural-assessment-of-uterine-artery-embolization-100610658",false,"NCT07230444","Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization","Validation and Implementation With Artificial Intelligence of Software for the Intra-procedural Assessment of Uterine Artery EMBOlization","AI-EMBO","Inclusion Criteria:\n\n* Female patients ≥18 years\n* Symptomatic uterine fibroids (e.g., bleeding, bulk symptoms, pain)\n* Underwent UAE as definitive therapy\n* Availability of baseline clinical\u002Fimaging data (for retrospective arm) or ability to provide informed consent (for prospective arm)\n\nExclusion Criteria:\n\n* Lack of clinical follow-up\n* Poor quality or incomplete angiographic images.","FEMALE","18 Years","55 Years",{"count":21,"type":22},250,"ESTIMATED","6 Months","OBSERVATIONAL","Uterine artery embolization is a minimally invasive treatment for symptomatic uterine fibroids, but intra-procedural assessment of embolization adequacy currently relies on subjective angiographic criteria. This study evaluates a proprietary angiographic analysis software (AQ-VERO) that extracts quantitative time-to-density perfusion metrics in real time. The study aims to (1) validate the accuracy and reproducibility of AQ-VERO during uterine artery mebolization, and (2) develop an AI-based decision support system using AQ-VERO-derived metrics to improve objective intra-procedural assessment of treatment endpoints.",[27],"Uterine Fibroids (UF)",[29,30,31,32,33],"uterine fibroids","embolization","uterine artery embolization","quantitative imaging","artificial intelligence","NOT_YET_RECRUITING","2025-11-15",{"date":37,"type":38},"2025-11-19","ACTUAL",{"date":40,"type":22},"2025-12-01",{"date":42,"type":22},"2027-05-31",{"name":44,"class":45},"Emanuele Barabino","OTHER",""]